{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T16:50:27Z","timestamp":1786812627456,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jiac.2024.01.018","type":"journal-article","created":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T01:45:54Z","timestamp":1707011154000},"page":"812-814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Minimal impact of low-density lipoprotein apheresis on vancomycin serum concentration: A case report"],"prefix":"10.1016","volume":"30","author":[{"given":"Yoko","family":"Hiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9118-0411","authenticated-orcid":false,"given":"Takashi","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"42","key":"10.1016\/j.jiac.2024.01.018_bib1","article-title":"The pharmacokinetic and pharmacodynamic properties of vancomycin","volume":"1","author":"Rybak","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"14","key":"10.1016\/j.jiac.2024.01.018_bib2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/pharmaceutics14030489","article-title":"Clinical practice guidelines for therapeutic drug monitoring of vancomycin in the framework of model-informed precision dosing: a consensus review by the Japanese society of chemotherapy and the Japanese society of therapeutic drug monitoring","volume":"23","author":"Matsumoto","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jiac.2024.01.018_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12028-020-00989-1","article-title":"Drug dosing in patients undergoing therapeutic plasma exchange","volume":"34","author":"Mahmoud","year":"2021","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.jiac.2024.01.018_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/cc1516","article-title":"Clinical review: use of vancomycin in haemodialysis patients","volume":"6","author":"Launay-Vacher","year":"2002","journal-title":"Crit Care"},{"key":"10.1016\/j.jiac.2024.01.018_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American society for apheresis: the ninth special issue","volume":"38","author":"Connelly-Smith","year":"2023","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jiac.2024.01.018_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/1744-9987.13891","article-title":"Angiographic and clinical impact of novel low-density lipoprotein apheresis for no-option chronic limb-threatening ischemia","volume":"27","author":"Kojima","year":"2023","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jiac.2024.01.018_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10157-007-0003-8","article-title":"Applications of LDL-apheresis in nephrology","volume":"12","author":"Kobayashi","year":"2008","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jiac.2024.01.018_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tmrv.2022.12.003","article-title":"State of the evidence: drug removal via apheresis","volume":"37","author":"Binns","year":"2023","journal-title":"Transfus Med Rev"},{"issue":"7","key":"10.1016\/j.jiac.2024.01.018_bib9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41598-017-00685-9","article-title":"VLDL\/LDL acts as a drug carrier and regulates the transport and metabolism of drugs in the body","volume":"4","author":"Yamamoto","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiac.2024.01.018_bib10","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1177\/106002809703101003","article-title":"Removal of vancomycin during plasmapheresis","volume":"31","author":"McClellan","year":"1997","journal-title":"Ann Pharmacother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24000291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24000291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T19:39:22Z","timestamp":1731181162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24000291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1341321X24000291"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.01.018","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimal impact of low-density lipoprotein apheresis on vancomycin serum concentration: A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}